Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Karleen Marie Oberton Insider Profile
4 Followers
Karleen Marie Oberton, CFO at Hologic, holds 57.40K shares in Hologic (Ticker: HOLX), holds 0.00 shares in ImmunoGen (Ticker: IMGN).
Karleen Marie Oberton has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Karleen Marie Oberton holds in companies
Most Profitable Insider Trade
The most profitable trade made by Karleen Marie Oberton
Karleen Marie Oberton's Trading History
Hologic
Nov 12, 2020
CFO
Uninformative Buy
―
$3.99M
ImmunoGen
―
Senior Corporate Controller
―
$0.00
List of latest transactions for each holding click on a transaction to see Karleen Marie Oberton's performance on stock
You May Also Like
Karleen Marie Oberton insider profile FAQ
What is the percentage of profitable transactions made by Karleen Marie Oberton?
The percentage of profitable transactions made by Karleen Marie Oberton is ―.
What is the average return per transaction made by Karleen Marie Oberton?
The average return per transaction made by Karleen Marie Oberton is ―.
What stocks does Karleen Marie Oberton hold?
Karleen Marie Oberton holds: HOLX, IMGN stocks.
What was Karleen Marie Oberton’s latest transaction?
Karleen Marie Oberton latest transaction was an Uninformative Buy of ―.
What was Karleen Marie Oberton's most profitable transaction?
Karleen Marie Oberton’s most profitable transaction was an Informative Buy of HOLX stock on November 5, 2014. The return on the trade was 51.00%.
What is Karleen Marie Oberton's role in Hologic?
Karleen Marie Oberton's role in Hologic is CFO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.